Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
10:00am, Tuesday, 18'th Jun 2024
High-yield dividend stocks can be potent long-term value creators. Pharma titans Pfizer and Bristol Myers Squibb sport two of the highest yields within their peer group.
Bristol Myers Squibb Announces Dividend
06:59am, Tuesday, 18'th Jun 2024
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Announces Dividend.
7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
03:27pm, Monday, 17'th Jun 2024
Biotech stocks operate under a core ethos. While there's been much talk about financially viable sectors – from tech to cryptocurrencies to even precious metals – when you think about it, nothing
6 of Wall Street's Favorite High-Yield Blue Chip Dividend Stocks to Buy in June
08:28am, Monday, 17'th Jun 2024
24/7 Insights Quality dividend stocks can generate solid total returns and yield passive income.
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade
05:57pm, Saturday, 15'th Jun 2024
Pfizer stock has been beaten down so far that it offers a dividend yield above 6% at recent prices. Bristol Myers Squibb has been trading for the low multiple of about 7 times trailing free cash flow.
Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro
02:31pm, Friday, 14'th Jun 2024
The FDA approves Bristol Myers' (BMY) cancer drug Augtyro for the treatment of adult and pediatric patients aged 12 years and older with solid tumors that have a neurotrophic tyrosine receptor kinase
Goldman Sachs Has 6 High-Yield Dividend Stocks to Buy in June
07:58am, Friday, 14'th Jun 2024
The artificial intelligence rally over the past year and a half, led by the so-called Magnificent 7 stocks, has been remarkable if you owned those stocks.
3 High-Yield Dividend Stocks for Income Now and Growth Later
07:05am, Friday, 14'th Jun 2024
The latest readings on inflation show some cooling, and stocks seem to like it. However, it's important to be clear about why investors feel bullish.
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Augtyro--U.S. FDA Approves Augtyro™ (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), for the Treatment of Patients with NTRK-Positive.
Bristol-Myers Squibb: Move Investing Time Horizon To 2025, At Least
04:13pm, Thursday, 13'th Jun 2024
Bristol-Myers Squibb Company stock has taken a big tumble in the past quarter following its sharply reduced earnings guidance, but there are still plenty of positives going for it. Better than expecte
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
10:33am, Thursday, 13'th Jun 2024
Bristol Myers (BMY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Dividend Harvesting Portfolio Week 171: $17,100 Allocated, $1,524.12 In Projected Dividends
09:00am, Thursday, 13'th Jun 2024
The markets had a strong week, with the S&P 500 gaining 0.97% and the Dow Jones Industrial Average gaining 1.6%. Yields on the 10-year Treasury shot up to 4.9% ahead of the FOMC meeting. The Dividend
Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb
01:50am, Wednesday, 12'th Jun 2024
Key scientific achievement advances the joint pipeline in the strategic neuroscience partnership with Bristol Myers Squibb and earns a payment of US$ 20 m to Evotec to progress further research HAMBUR
Bristol Myers Squibb (BMY) Beats Stock Market Upswing: What Investors Need to Know
06:50pm, Tuesday, 11'th Jun 2024
Bristol Myers Squibb (BMY) reachead $43.02 at the closing of the latest trading day, reflecting a +1.06% change compared to its last close.
Bristol-Myers Squibb Company (BMY) Goldman Sachs 45th Annual Global Healthcare Conference
02:35pm, Tuesday, 11'th Jun 2024
Bristol-Myers Squibb Company (NYSE:BMY ) Goldman Sachs 45th Annual Global Healthcare Conference June 11, 2024 11:20 AM ET Company Participants Chris Boerner - Board Chair and Chief Executive Officer C
